A Study to Assess the Impact of Pneumococcal Conjugate Vaccination Programme on the Carriage of Pneumococci
NCT01040143 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 450
Last updated 2019-03-22
Summary
A study taking swabs from the back of the nose (nasopharynx) to look at carriage of pneumococci.
Conditions
- Pneumococcal Disease
Sponsors & Collaborators
-
Public Health England
lead OTHER_GOV
Eligibility
- Min Age
- 1 Year
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-01-31
- Primary Completion
- 2010-03-31
- Completion
- 2010-03-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Carriage to Assess Protection of New Pneumococcal Vaccines - PCV15
NCT06731374 ·Status: RECRUITING ·Phase: PHASE4
-
Study Evaluating the Effiacy of a 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in Adults
NCT00744263 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluating Vaccine Responses in Healthy Infants Receiving Their Routine Primary Immunisation According to the Accelerated United Kingdom Schedule at 2, 3 and 4 Months
NCT01425372 ·Status: COMPLETED
-
Study of Two Investigational Pneumococcal Vaccines in Healthy Adults
NCT01444339 ·Status: COMPLETED ·Phase: PHASE1
-
Study of an Investigational Pneumococcal Vaccine at Three Dose Levels in Healthy Adults
NCT01444352 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Assessing 13-valent Pneumococcal Conjugate Vaccine in Healthy Chinese Subjects
NCT01531322 ·Status: COMPLETED ·Phase: PHASE1
-
Long-term Impact of Pneumococcal Conjugate Vaccine on Carriage
NCT00294021 ·Status: COMPLETED
-
Nasopharyngeal Carriage Study in Healthy Kenyan Toddlers
NCT02146365 ·Status: COMPLETED
-
Study Evaluating the Nasopharyngeal Carriage in Healthy Children
NCT00768833 ·Status: COMPLETED
-
Understanding Pneumococcal Carriage and Disease
NCT01996007 ·Status: COMPLETED
-
Study Evaluating Streptococcus Pneumoniae Nasopharyngeal Carriage Rate in Children Receiving Prevnar®
NCT00488371 ·Status: COMPLETED
-
Phase Ⅱ Clinical Trial of 24-valent Pneumococcal Polysaccharide Conjugate Vaccine
NCT07035054 ·Status: COMPLETED ·Phase: PHASE2
-
PCV7 in the Prevention of Nasopharyngeal Carriage of Vaccine Serotype (VT) Streptococcus Pneumoniae
NCT02133469 ·Status: COMPLETED ·Phase: NA
-
Streptococcus Pneumonia: Effects of PCV13 on Pneumococcal Carriage
NCT01109108 ·Status: COMPLETED
-
Evaluation of the Immunogenicity and Reactogenicity of a Pneumococcal Conjugate Vaccine in Healthy Adults
NCT00197821 ·Status: COMPLETED ·Phase: PHASE2
-
PCV13 in Non-pregnant Papua New Guinean Women
NCT04183322 ·Status: COMPLETED
-
Safety and Immunogenicity of 10-valent and 13-valent Pneumococcal Conjugate Vaccines in Papua New Guinean Children
NCT01619462 ·Status: UNKNOWN ·Phase: PHASE3
-
PCV13 Impact on Pneumococcal Nasopharyngeal Carriage Study
NCT05114902 ·Status: UNKNOWN
-
PREVENTING PNEUMOcoccal Disease Through Vaccination (Study 2)
NCT04974294 ·Status: UNKNOWN ·Phase: PHASE4
-
Safety, Tolerability, and Efficacy Study of Prophylactic S. Pneumoniae Vaccine Following Challenge With S. Pneumoniae
NCT02116998 ·Status: COMPLETED ·Phase: PHASE2
-
Study of an Investigational Pneumococcal Vaccine in Healthy Adult Volunteers
NCT01444001 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Investigational Pneumococcal Vaccine in Healthy Adults, Toddlers and Infants
NCT01446926 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Assessing 13-valent Pneumococcal Conjugate Vaccine in Healthy Chinese Infants and Young Children
NCT03574389 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity of Pneumococcal Conjugate Formulations in Healthy Adults 18 Through 49 Years of Age
NCT05489328 ·Status: COMPLETED ·Phase: PHASE1
-
Study Evaluating The Safety, Tolerability And Immunogenicity Of A 13-Valent Pneumococcal Conjugate Vaccine (13vPnC)
NCT00546572 ·Status: COMPLETED ·Phase: PHASE3